Business & Finance
KalVista Pharmaceuticals incurs higher net loss of USD5.0m for fiscal Q1
17 September 2018 - Pharmaceutical company KalVista Pharmaceuticals Inc (NASDAQ:KALV) stated on Friday that it recorded a net loss of USD5.0m (USD0.47 per basic and diluted share) for the fiscal first...
Gollaher Named to Cidara Therapeutics Board of Directors
14 September 2018 - - US-based biotechnology company Cidara Therapeutics, Inc. (NASDAQ: CDTX) has appointed indus David Gollaher, Ph.D., to the company's board of directors, the company said.
BioArctic enters into research agreement with Brain Biomarker Solutions in Gothenburg AB for new diagnostics development for Alzheimer's
14 September 2018 - Swedish research-based biopharmaceutical company BioArctic AB (STO:BIOAB) announced on Thursday the signing of a research agreement with Brain Biomarker Solutions in Gothenburg AB ...
Medicover completes acquisition of Spitalul Pelican
13 September 2018 - Medicover AB (STO:MCOVB), a healthcare and diagnostic services company, announced on Wednesday the completion of the acquisition of a majority stake of Spitalul Pelican, as all nec...
Novocure and Zai Lab Ink License Agreement for Tumor Treating Fields in Greater China
12 September 2018 - - Jersey-based oncology company Novocure (NASDAQ: NVCR) and China-based biopharmaceutical company Zai Lab (NASDAQ: ZLAB) have inked an exclusive license agreement for Tumor Treatin...
AbbVie's board approves USD0.96 per share dividend for quarter
10 September 2018 - The board of directors of AbbVie Inc (NYSE:ABBV) approved a quarterly dividend of USD0.96 per share of the company's stock, it declared on Friday.This cash dividend is due on ...